According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period (2021-2031). Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health.
Market demand is set to rise at a steady pace throughout the forecast period, majorly favored by investments outside the boundaries of healthcare towards a branched approach involving domains such as workplace regulations, financial equity, and state legislation.
The primary factor supporting the femtech market to positive expansion in terms of growth and stability is the advent of digitalization and artificial intelligence. Technological advancements such as cloud-based informatics allow personalized solutions, driven by consumer input. This has given rise to affordable and accessible analysis in terms of personal health monitoring and diagnosis.
Key market players have pushed for innovation and accessibility into customized digital solutions. This also includes the introduction of hands-free wearables which are assistive with the regular, day-to-day life of women across the globe.
Additionally, leading product developers in the femtech market work through commercial partners such as department stores, big-box retailers, hospitals, clinics, insurance companies, pharmacies and drugstores, private medical practices and e-commerce platforms to expand product sales prospects.
“The advent of technological improvements in healthcare in the form of devices, applications, services, and products has increased the rate of diagnosis of reproductive disorders in terms of time management and treatments for women. This will aid growth through the upcoming decade,” says the FMI Analyst
Key Takeaways from Femtech Market Study
Menstrual health applications will drive market growth holding around a third of the market, supported by growing purchases from the working women demographic.
Diagnostic services are projected to cover about 45% of the global market by 2031. This is aided by the growing accessibility of digital health services
The U.S. holds a dominant share, valuing at over US$ 357.1 Mn by the end of 2021, supported by the presence of leading players and higher consumer acceptance.
The U.K. and Germany dominate the Europe market, cumulatively accounting for more than 25% of the regional revenue.
China is a leading market in East Asia, and is forecast to account for more than 50% of the regional value share owing to a vast consumer base.
Who is Winning?
Some of the leading companies operating in the femtech market are focusing on collaborations with leading institutions for increasing awareness among the population about the adoption of digital health services.
Collaborations with key pharmaceutical companies to launch customized products and services for the growing consumer base has led key players to retain their position in the market while expanding their product portfolio.
Research collaboration in monitoring fetal heart rates through wearable ECG chips by between Bloomlife and Imec in 2019 has expectantly given rise to superior monitoring capabilities in maternity care.
Femtech companies have integrated applications for tracking fertility and offer services such as in-vitro fertilization. Additionally, they also offer medical treatments and products such as wearables and hands-free devices.
Femtech by Category
By Service
Diagnostics
Monitoring
Therapeutic
By Application
General Health and Wellness
Maternity Care
Menstrual Health
Pelvic and Uterine Healthcare
Cancer and Chronic Disease
By End User
Direct-to-consumer
Hospitals
Surgical Centers
Fertility Clinics
Diagnostics Centers
By Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa (MEA)
Information Source:
https://www.futuremarketinsights.com/reports/femtech-market